Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and molecular characteristics and prognostic factors of diffuse astrocytoma, IDH-wildtype, not elsewhere classified.

Journal of neuro-oncology - 1 Dec 2025

Cho Woo Jong, Choi Kaeum, Han Kyunghwa, Choi Seo Hee, Yoon Hong In, Ahn Sung Soo, Chang Jong Hee, Kang Seok-Gu, Kim Se Hoon, Lee Seung-Koo, Wee Chan Woo, Park Yae Won

Abstract excerpt

PURPOSE: The clinical nature of IDH-wildtype astrocytoma, not elsewhere classified (NEC), is poorly understood. To this end, we aimed to investigate the clinical, molecular, imaging, and prognosis of histological grade 2 and 3 IDH-wildtype diffuse astrocytoma, NEC. METHODS: Retrospective chart and imaging reviews were performed for 46 patients with IDH-wildtype diffuse astrocytoma, NEC. Data regarding clinical,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Brain Neoplasms

Share to Follow-Up Studies

Share to Isocitrate Dehydrogenase

Share to Ki-67 Antigen

Share to Magnetic Resonance Imaging

Share to Survival Rate

Source

Identifiers

PMID: 41324809
DOI: 10.1007/s11060-025-05358-6

Genes

ATM
KIT
PDGFRA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and molecular characteristics and prognostic factors of diffuse astrocytoma, IDH-wildtype, not elsewhere classified.PMID 41324809Read ↗

Clinical and radiographic characteristics of diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma: a single institution review.Semantic proximity Read ↗

Diffuse Gliomas for Nonneuropathologists: The New Integrated Molecular Diagnostics.Semantic proximity Read ↗

IDH wild-type grade 2 diffuse astrocytomas: prognostic factors and impact of treatments within molecular subgroups.Semantic proximity Read ↗

Clinical, histopathological, and molecular features of IDH-wildtype indolent diffuse glioma: comparison with typical glioblastoma.Semantic proximity Read ↗

Beyond IDH-Mutation: Emerging Molecular Diagnostic and Prognostic Features in Adult Diffuse GliomasSemantic proximity Read ↗

Imaging features of localized IDH wild-type histologically diffuse astrocytomas: a single-institution case series.Semantic proximity Read ↗

IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification.Semantic proximity Read ↗

[Update on the 2016 WHO classification of tumors of the central nervous system - Part 1: Diffusely infiltrating gliomas].Semantic proximity Read ↗

Molecular Characterization of “True” Low-Grade IDH-Wildtype AstrocytomasSemantic proximity Read ↗

Molecular Characterization of IDH Wild-type Diffuse Astrocytomas: The Potential of cIMPACT-NOW Guidelines.Semantic proximity Read ↗

Adult-type Diffuse Gliomas.Semantic proximity Read ↗

Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.